JAKMIP1 divergent transcript (JAKMIP1-DT)

JAKMIP1-DT (JAKMIP1 divergent transcript), also known as LINC02495, is a gene classified as a long non-coding RNA (lncRNA), not as a protein-coding gene or therapeutic target. Its official identifiers include HGNC: 27728, NCBI Gene: 285484, and Ensembl: ENSG00000249896[4][5]. Unlike the protein-coding JAKMIP1 gene, which encodes Janus kinase and microtubule interacting protein 1 involved in neural functions, JAKMIP1-DT's functions, roles in disease, interactions, and use as a therapeutic target are unknown or not supported by evidence[4][5]. There is no evidence it is utilized as a drug target or that it encodes a receptor, enzyme, or any molecule typically targeted by therapeutics. JAKMIP1-DT is frequently confused with the protein-coding gene JAKMIP1, but JAKMIP1-DT is an lncRNA (long non-coding RNA) and does not encode a protein[4][5]. There is no evidence it is a therapeutic target, nor is it a receptor, enzyme, or another typical druggable molecule. No interacting drugs, known biomarkers, or known relevant safety or clinical implications currently exist for JAKMIP1-DT, and its biological function is not established. This means that, for most clinical, pharmacological, and target discovery contexts, JAKMIP1-DT is not considered a valid or relevant target, and its use as such would be incorrect[4][5].

Other names

LINC02495